TacMed Australia announced it has formed a partnership with Rheinmetall Defence Australia (RDA) to develop a Lynx KF 41 ambulance variant to be offered in RDA’s tender submission for Project Land 400 Phase 3.
Image photoshopped by CONTACT.
TacMed, an emergency medical company that develops equipment, training and consulting solutions for high-risk organisations and environments, joined Team Lynx as a result of the Commonwealth’s Australian Industry Capability roadshow in the first half of 2020.
This opened the way for the veteran-owned company to become an industry partner in the bid to deliver the best infantry fighting vehicles (IFV) to the Australian Army under Land 400 Phase 3.
TacMed CEO Jeremy Holder said RDA selected his company because of its unique tactical medical experience and ability to provide specialised consulting services in the design of the vital ambulance variant to support modern-day warriors on the battlefield.
“This is a significant partnership for TacMed Australia and it aligns with our mission of zero preventable deaths at the point of injury, no matter the environment,” Mr Holder said.
“It cements our position as a leader in the field of critical casualty care in high-threat and complex environments.
“With over half of our company being former serving members of the ADF, TacMed will use its experience on the battlefields of Iraq and Afghanistan to play a role in developing the next generation of Australia’s armoured vehicles to protect and save soldiers’ lives.”
TacMed Australia is currently engaged with numerous government agencies and private industry, providing bespoke emergency medical training and equipment solutions.
If chosen for Land 400 Phase 3, the Lynx fleet will be manufactured in Queensland at Rheinmetall’s new Military Vehicle Centre of Excellence at Redbank, south west of Brisbane.